Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis

New Microbiologica

Volumn 37, Issue 2, 2014, Pages 129-143

  Mazibrada, Jasenk ^a   Longo, Luis ^a   Vatrano, Simon ^a   Cappia, Susann ^a   Giorcelli, Jessic ^a   Pentenero, Monic ^a   Gandolfo, Sergi ^a   Volante, Marc ^a   Dell'Oste, Valentin ^b   Lo Cigno, Iren ^b   Biolatti, Matte ^b   Landolfo, Sant ^b   Papotti, Maur ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Dysplasia; Head and neck; Her2; HPV; IFI16; SOX2; Squamous carcinoma

Indexed keywords

CELL CYCLE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; IFI16 PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; SOX2 PROTEIN, HUMAN; STAT3 PROTEIN; TRANSCRIPTION FACTOR SOX;

ADULT; ARTICLE; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; METABOLISM; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOPHYSIOLOGY; PHYSIOLOGY; UPREGULATION; VIROLOGY;

ADULT; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PAPILLOMAVIRUS INFECTIONS; PHOSPHOPROTEINS; RECEPTOR, ERBB-2; SOXB1 TRANSCRIPTION FACTORS; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84900393249     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Aglipay J. A., Lee S. W., Okada S., Fujiuchi N., Ohtsuka T., Kwak J. C., Wang Y., Johns tone R. W., Deng C., Qin J. and Ouchi T. (2003). A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene. 22, 8931-8938.
2. Al Moustafa A. E., Kass ab A., Darnel A. and Yasm een A. (2008). High-risk HPV/ErbB-2 interaction on Ecadherin/ catenin regulation in human carcinogenesis. Curr. Pharm. Des. 14, 2159-2172.
3. Azzimonti B., Pagano M., Mondini M., De Andrea M., Valente G., Monga G., Tomm asino M., Aluff i P., Landolfo S., Gariglio M. (2004). Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology. 45, 560-572.
4. Baxter F. O., Neoh K., Tevendale M. C. (2007). The beginning of the end: death signaling in early involution. J. Mammary Gland. Biol. Neoplasia. 12, 3-13.
5. Brcic L., Sherer C. K., Shuai Y., Hornick J. L., Chirieac L. R., Dacic S. (2012). Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2. Am. J. Clin. Pathol. 138, 712-718.
6. Cappuzzo F., Varella-Garcia M., Shigematsu H., Domenichini I., Bartolini S., Ceresoli G. L., Ross i E., Ludovini V., Gregorc V., Toschi L., Franklin W. A., Crino L., Gazdar A. F., Bunn P. A. Jr. and Hirsch F. R. (2005). Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive nonsmall- cell lung cancer patients. J. Clin. Oncol. 23, 5007-5018.
7. Cardesa A., Nadal A. (2011). Carcinoma of the head and neck in the HPV era. Acta Dermatovenerol. Alp. Panonica Adriat. 20, 161-173.
8. Citri A., Yarden Y. (2006). EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell. Biol. 7, 505-516.
9. Clarkson R. W., Boland M. P., Kritikou E. A., Lee J. M., Freeman T. C., Tiff en P. G. and Watson C. J. (2006). The genes induced by signal transducer and activators of transcription (STAT) 3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol. Endocrinol. 20, 675-685.
10. Costa S., Borgogna C., Mondini M., De Andrea M., Meroni P. L., Berti E., Gariglio M., Landolfo S. (2011). Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. Br. J. Dermatol. 164, 282-290.
11. Couto J. P., Daly L., Almeida A., Knauf J. A., Fagin J. A., Sobrinho-Simoes M., Lima J., Maximo V., Soares P., Lyden D., Bromberg J. F. (2012). STAT3 negatively regulates thyroid tumorigenesis. Proc. Natl. Acad. Sci. USA. 109, E2361-2370.
12. Curado M. P., Hashibe M. (2009). Recent changes in the epidemiology of head and neck cancer. Curr. Opin. Oncol. 21, 194-200.
13. Denton K. J., Bergeron C., Klement P., Trunk M. J., Keller T., Ridder R., European C. C. S. G. (2010). The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results. Am. J. Clin. Pathol. 134, 12-21.
14. Dietary guidelines for Americans. 6th ed. Washington, DC. http://www. health. gov/dietaryguidelines/ dga2005/document/
15. Dolled-Filhart M., Camp R. L., Kowalski D. P., Smith Rimm B. L. (2003). Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in nodenegative breast cancer shows nuclear localization is associated with a better prognosis. Clin. Cancer. Res. 9, 594-600.
16. Ettl T., Stiegler C., Zeitler K., Agaimy A., Zenk J., Reichert T. E., Gosau M., Kuhnel T., Brockhoff G., Schwarz S. (2012). EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis. Hum. Pathol. 43, 921-931.
17. Furniss C. S., McClean M. D., Smith J. F., Bryan J., Applebaum K. M., Nelson H. H., Posn er M. R., Kelsey K. T. (2009). Human papillomavirus 6 seropositivity is associated with risk of head and neck squamous cell carcinoma, independent of tobacco and alcohol use. Ann. Oncol. 20, 534-541.
18. Gariglio M., Azzimonti B., Pagano M., Palestro G., De Andrea M., Valente G., Voglino G., Navino L., Landolfo S. (2002). Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J. Interferon. Cytokine Res. 22, 815-821.
19. Goon P. K., Stanley M. A., Ebmeyer J., Steins trass er L., Upile T., Jerjes W., Bernal-Sprekelsen M., Gorner M., Sudhoff H. H. (2009). HPV & head and neck cancer: a descriptive update. Head Neck Oncol. 1, 36.
20. Goubau D., Rehwinkel J., Reis e Sousa C. (2010). PYHIN proteins: center stage in DNA sensing. Nat. Immunol. 11, 984-986.
21. Hirsch F. R., Varella-Garcia M., McCoy J., West H., Xavier A. C., Gumerlock P., Bunn P. A. Jr., Franklin W. A., Crowley J., Gandara D. R., Southwest Oncology G. (2005). Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study. J. Clin. Oncol. 23, 6838-6845.
22. Hoffm ann T. K., Sonkoly E., Hauser U., van Lierop A., Whiteside T. L., Klussm ann J. P., Hafn er D., Schuler P., Friebe-Hoffm ann U., Scheckenbach K., Erjala K., Grenm an R., Schipper J., Bier H., Balz V. (2008). Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol. 44, 1100-1109.
23. Kim E. J., Park J. I., Nelkin B. D. (2005). IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. J. Biol. Chem. 280, 4913-4920.
24. Kostareli E., Holzinger D., Hess J. (2012). New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas. Front. Oncol. 2, 36.
25. Lai S. Y., Johns on F. M. (2010). Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Drug. Resist. Updat. 13, 67-78.
26. Leemans C. R., Braakhuis B. J., Brakenhoff R. H. (2011). The molecular biology of head and neck cancer. Nat. Rev. Cancer. 11, 9-22.
27. Levy D. E., Darnell J. E. Jr. (2002). Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol. 3, 651-662.
28. Lingen M. W., Xiao W., Schmitt A., Jiang B., Pickard R., Kreinbrink P., Perez-Ordonez B., Jordan R. C., Gillison M. L. (2013). Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 49, 1-8.
29. Liu S. P., Harn H. J., Chien Y. J., Chang C. H., Hsu C. Y., Fu R. H., Huang Y. C., Chen S. Y., Shyu W. C., Lin S. Z. (2012). n-Butylidenephthalide (BP) maintains stem cell pluripotency by activating Jak2/Stat3 pathway and increases the efficiency of iPS cells generation. PLoS One. 7, e44024.
30. Maier S., Wilbertz T., Braun M., Scheble V., Reischl M., Mikut R., Menon R., Nikolov P., Petersen K., Beschorner C., Moch H., Kakies C., Protzel C., Baue J., Soltermann A., Fend F., Staebler A., Lengerke C., Perner S. (2011). SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum. Pathol. 42, 1078-1088.
31. Masuda M., Wakasaki T., Toh S., Shimizu M., Adachi S. (2011). Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG-The Role of EGFR Signaling and "Lipid Raft". J. Oncol. 2011, 540148.
32. Mondini M., Costa S., Sponza S., Gugliesi F., Gariglio M., Landolfo S. (2010). The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. Autoimmunity. 43, 226-231.
33. Monn ien F., Zaki H., Borg C., Mougin C., Boss et J. F., Mercier M., Arbez-Gindre F., Kantelip B. (2010). Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial. J. Clin. Pathol. 63, 873-878.
34. Morgan S., Grandis J. R. (2009). ErbB receptors in the biology and pathology of the aerodigestive tract. Exp. Cell. Res. 315, 572-582.
35. Ni Z., Bremn er R. (2007). Brahma-related gene 1-dependent STAT3 recruitment at IL-6-inducible genes. J. Immunol. 178, 345-351.
36. Pectasides E., Egloff A. M., Sasaki C., Kountourakis P., Burtness B., Fountzilas G., Dafni U., Zaramboukas T., Rampias T., Rimm D., Grandis J., Psyrri A. (2010). Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis. Clin. Cancer. Res. 16, 2427-2434.
37. Rampias, T., Sasaki C., Weinberger P., Psyrri A. (2009). E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J. Natl. Cancer. Inst. 101, 412-423.
38. Robins on M., Sloan P., Shaw R. (2010). Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral. Oncol. 46, 492-496.
39. Rodriguez-Pinilla S. M., Sarrio D., Moreno-Bueno G., Rodriguez-Gil Y., Martinez M. A., Hernandez L., Hardiss on D., Reis-Filho J. S., Palacios J. (2007). Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod. Pathol. 20, 474-481.
40. Rogers S. J., K. J. Harrington, Rhys-Evans P., O. C. P, S. A. Eccles (2005). Biological significance of cerbB family oncogenes in head and neck cancer. Cancer Metastasis Rev. 24, 47-69.
41. Seme K., Lepej S. Z., Lunar M. M., Iscic-Bes J., Planinic A., Kocjan B. J., Vince A., Poljak M. (2009). Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes. J. Clin. Virol. 46, 176-179.
42. Services USDoHaH, Agriculture USDo. Dietary guidelines for Americans. 6th ed. Washington, DC: U. S.: Government Printing Office; 2005. 84.
43. Sheu J. J., Hua C. H., Wan L., Lin Y. J., Lai M. T., Tseng H. C., Jinawath N., Tsai M. H., Chang N. W., Lin C. F., Lin C. C., Hsieh L. J., Wang T. L., Shih Ie M. and Tsai F. J. (2009). Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma. Cancer Res. 69, 2568-2576.
44. Singh S., Trevino J., Bora-Singhal N., Coppola D., Haura E., Altiok S., Chellappan S. P. (2012). EGFR/ Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol. Cancer. 11, 73.
45. Smeets S. J., Hess elink A. T., Speel E. J., Haesevoets A., Snijders P. J., Pawlita M., Meijer C. J., Braakhuis B. J., Leemans C. R., Brakenhoff R. H. (2007). A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int. J. Cancer. 121, 2465-2472.
46. Sriuranpong V., Park J. I., Amornphimoltham P., Patel V., Nelkin B. D., Gutkind J. S. (2003). Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res. 63, 2948-2956.
47. Straight S. W., Herman B., McCance D. J. (1995). The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69, 3185-3192.
48. Temam S., Kawaguchi H., El-Naggar A. K., Jelinek J., Tang H., Liu D. D., Lang W., Iss a J. P., Lee J. J., Mao L. (2007). Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J. Clin. Oncol. 25, 2164-2170.
49. Thariat J., Milas L., Ang K. K. (2007). Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 69, 974-984.
50. Unterholzner L., Keating S. E., Baran M., Horan K. A., Jens en S. B., Sharma S., Sirois C. M., Jin T., Latz E., Xiao T. S., Fitzgerald K. A., Paludan S. R., Bowie, A. G. (2010). IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997-1004.
51. Utikal J., Polo J. M., Stadtfeld M., Maherali N., Kulaler W., Wals R. M., Khalil A., Rheinwald J. G., Hochedlinger K. (2009). Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature. 460, 1145-1148.
52. Yarden Y., Sliwkowski M. X. (2001). Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2, 127-137.
53. Zhong Z., Wen Z., Darnell J. E. Jr. (1994). Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 264, 95-98.
54. zur Hausen H. (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer. 2, 342-350.